Outcomes in pulmonary sarcoidosis: results of a newly implemented prednisone protocol

BACKGROUND AND AIM: Prednisone is used as first-line therapy for patients with pulmonary sarcoidosis. There is however no clear association between prednisone dose and FVC change in patients with pulmonary sarcoidosis. In order to improve our standard of care we introduced a more conservative predni...

Descripción completa

Detalles Bibliográficos
Autores principales: Kampstra, Nynke A, van der Wees, Philip J, van Beek, Frouke, Biesma, Douwe H, Grutters, Jan C., van der Nat, Paul B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099653/
https://www.ncbi.nlm.nih.gov/pubmed/36975054
http://dx.doi.org/10.36141/svdld.v40i1.13574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099653/
https://www.ncbi.nlm.nih.gov/pubmed/36975054
http://dx.doi.org/10.36141/svdld.v40i1.13574

Ejemplares similares